Pivoting to community-based research models to boost patient access
South Korea’s clinical trial ecosystem is shifting from decentralised trials to broader community-based models to improve patient access.
Transforming Clinical Trials
South Korea and Australia offer solutions for radiopharma trial bottlenecks
Increasing trial activity in APAC region influences commercial supply chains
Driving digital solutions through rapid experimentation
Strategies to optimise patient engagement and retention in clinical trials
Using AI to forge the future of rare disease clinical trials
Adapting to funding and operational hurdles in today’s clinical trials landscape
AI could personalise clinical trial consent, but privacy concerns remain
